Both heme oxygenase-1 (HO-1) and p21 WAF1/Cip1 (p21) are involved in the pathogenesis of human cancer and their functions are closely associated with apoptosis. However, how these two molecules regulate apoptosis in human gastric cancer is unknown. In this study, we studied how HO-1 and p21 were regulated in two gastric cancer cell lines, MKN-45 with wild p53 and MKN-28 with mutant p53. The cells were treated with hemin and cadmium to induce HO-1. The result showed that HO-1 protein was significantly induced by hemin and cadmium in both cells tested. Following the HO-1 expression, p21 level was also markedly induced. The cells with increased HO-1 and p21 showed obviously resistantance to apoptotic stimuli. The levels of HO-1 and p21 induced were significantly inhibited by p38 mitogen-activated protein kinase (p38 MAPK) inhibitor (SB203580) and extracellular-regulated kinase (ERK) inhibitor (PD098059). Parallel to decreased HO-1 and p21 expression, the kinase inhibitors also significantly attenuated the resistance of the cells to apoptosis. The elevated HO-1 and p21 was further found to be associated with increase activity of the nuclear NFjB and the inhibition of NF-jB led to the block of their induction. The elevated HO-1 and p21 were also demonstrated to be related to increased cellular inhibitor of caspase inbitory protein-2 (c-IAP2) and decreased caspapse-3 activity. It was noted that the above changes observed were not different between MKN-45 and MKN-28 cells, suggesting the functions of HO-1 and p21 were irrespective of the status of p53. In conclusion, we demonstrate that the resistance to apoptosis in gastric cancer cells with elevated HO-1 and p21 is independent of p53 status in a p38 MAPK-and ERK-mediated pathway with elevated c-IAP2 and decreased caspase-3 activity and that this pathway is sensitive to the inhibition of NF-jB.
Introduction
Heme oxygenase (HO) is the rate-limiting enzyme of heme catabolism. It catalyses the breakdown of heme into equimolar amounts of carbon monoxide, iron and biliverdin. Three isoforms transcribed from separate genes have been characterized. HO-2 and HO-3 are primarily constitutive but HO-1 is highly inducible (Maines, 1988; McCoubrey et al., 1997) . In addition to its substrate heme, a variety of conditions and agents, both physiological and nonphysiological, including ultraviolet irradiation, hyperthermia, inflammatory cytokines and heavy metals, potently stimulate HO-1 expression. These and other stimuli share in common the ability to generate cellular oxidative stress, and thus HO-1 may be a quintessential stress-induced protein (Maines et al., 1999) . One common cellular response to oxidant stress is apoptosis (Chandra et al., 2000) and the involvement of oxidant in apoptosis makes HO-1 a good candidate as an antiapoptotic molecule. It is well known that apoptosis or programmed cell death is an active process in which a cell commits suicide for the benefit of the whole organism and this mode of cell death is critical in the development of a number of cancers. How HO-1 is involved in this process in gastric carcinoma is totally unknown, although the expression of HO-1 participates in the pathogenesis of several types of cancers (Murphy et al., 1993; Maines and Abrahamsson, 1996; Goodman et al., 1997) . Elevated expression or activity of HO-1 is reported to be associated with cellular proliferation in some tumors such as prostate cancer and renal adenovarcinoma (Maines and Abrahamsson, 1996; Goodman et al., 1997) . Its increased level correlates some molecules involved in cellular transformation such as p53 and estrogen receptor (Elledge et al., 1994; Takahashi et al., 1994) . p21 WAF1/Cip1 (p21) is first identified as a member of the family of cyclin-dependent kinase (CDK) inhibitors, which function to inhibit CDK-1, -2,-4 and -6 (Chellappan et al., 1998) . However, recent studies have shown that p21 can modulate multiple biological functions, including stem cell commitment, differentiation, DNA synthesis, stress response and apoptosis. As a negative regulator of growth, p21 could protect cells from apoptosis at three possible levels. First, p21 inhibits CDK whose activation is a necessary step for apoptosis (Hiromura et al., 1999) . Second, p21 interacts with several caspases, such as caspase-3, caspase-8 and caspase-10 ( Suzuki et al., 1998; Xu and El-Deiry, 2000) . Third, p21 is shown to induce genes of secreted proteins with antiapoptotic activities (Chang et al., 2000) . Finally, it is possible that p21 can protect against oxidative-induced toxicity and thus promote survival of cells (Helt et al., 2001) .
There is increasing evidence suggesting that the development of gastric cancer is associated with decrease in cell ability to go through apoptosis and that induction of apoptosis is a potential mediation to stop uncontrolled growth of gastric cancer cells (Wakana et al., 2002; Wu et al., 2003) . The aberrant expression of p21 has been documented in gastric cancer (Baas et al., 1998; Craanen et al., 1999; Baldus et al., 2001) . However, the mechanism responsible for its aberrant expression is not clear. The present study was to investigate how p21 is regulated in gastric cancer cells in the association with HO-1. As the function of p21 is closely related to p53, we chose two gastric cancer cell lines with different status of p53 gene for the study.
Results

Expression of HO-1, p21 and c-IAP2 in gastric cancer cells
The expression of HO-1 was observed in both MKN-45 (with wild p53) and MKN-28 (with mutate p53) cells ( Figure 1a ). It seemed that the level of HO-1 was higher in MKN-28 cells than in MKN-45 cells without either hemin or cadmium treatment, however, the difference appeared not to be significant. The level of HO-1 was significantly increased in both MKN-45 and MKN-28 cells when they were stimulated with hemin or cadmium, suggesting that both cells were able to respond to HO-1 inducers in a pathway independent of the status of p53. Since the p38 mitogen-activated protein kinase (p38 MAPK) and the extracellular-regulated kinase (ERK) are actively involved in the apoptosis induced by oxidants, we further examined whether the expression of HO-1 would be regulated by the inhibitors of p38 MAPK (SB203580) and ERK (PD098059). The result showed that the level of HO-1 was markedly reduced by either SB203580 or PD098059 (Figure 1a ), indicating that HO-1 was positively regulated by both p38 MAPK and ERK. The inhibition of HO-1 by SB203580 was much stronger than that by PD098059. The level of HO-1 in MKN-28 cells induced by cadmium and hemin was inhibited by about 50 and 80%, respectively, by SB203580, whereas it was suppressed by about 27 and 48%, respectively, by PD098059 (Figure 1b) . A similar pattern of HO-1 reduction was also found in MKN-45 cells, which further supported that the modulation of HO-1 level in the gastric cancer cells tested was independent of p53. The level of p21 was markedly elevated by hemin and cadmium in both MKN-28 and MKN-45 cells (Figure 1a) . We further observed that the increase in HO-1 predated the change of p21 in both MKN-28 and MKN-45 cells (Figure 2 , data for MKN-45 not shown). Like HO-1, the increase in p21 expression was sensitive to the kinase inhibitors SB203580 and PD098059, with the effect of SB203580 being more profound than that of PD098059 ( Figure 1a) .
The expression of cellular inhibitor of caspase inbitory protein-2 (c-IAP2) was also observed in both MKN-45 and MKN-28 cells. The level of c-IAP2 was significantly increased in both MKN-45 and MKN-28 cells when they were stimulated with hemin or cadmium. But the increased expression of c-IAP2 was diminished by the inhibitors of p38 MAPK (SB203580) and ERK (PD098059) (Figure 1 ). The inhibition of c-IAP2 by SB203580 was much stronger than that by PD098059. The modulation of c-IAP2 level in the gastric cancer cells tested was independent of p53. The time course study revealed that the increase in c-IAP2 postdated the induction of HO-1 by hemin or cadmium and its increase appeared at about the same time (3 h) as the increased p21 after the treatment (Figure 2 ).
HO-1 and p21 arrested cell growth in the G 0 /G 1 phases of cell cycle
To analyse the effect of the increase in HO-1 and p21 levels on the growth of MKN-45 and MKN-28 cells, we performed the cell cycle analysis using fluorescenceactivated cell sorter analysis (FACS). The induction of HO-1 and p21 levels by hemin and cadmium significantly increased the percentage of the cells in the G 0 /G 1 phases whereas it decreased the percentage of the cells in the S/G 2 /M phases ( Figure 3 ). The p53 status of the cells did not affect the change of the cell cycle, as the percentage of the cells in either the G 0 /G 1 phases or the S/G 2 /M phases was not different between the cells with wild-type 53 (MKN-45) and the cells with mutant 53 (MKN-28).
The expression of HO-1 and p21 inhibited cell death provoked by rhTNF-a and cycloheximide
To determine whether the upregulation of HO-1 and increased expression of p21 influenced vulnerability to Figure 1 The expression of HO-1, p21 and c-IAP2 proteins in gastric cancer cells. MKN-45 and MKN-28 cells were cultured in complete medium for 48 h, and subsequently, in serum-free medium for 24 h, and then were exposed to 10 mM hemin and 10 mM cadmium for 4 h. The kinase inhibitors 40 mM SB203580 and 40 mM PD098059 were added 1 h prior to the addition of hemin and cadmium. The total proteins were extracted, and the expression of HO-1, p21 and c-IAP2 were analysed by Western blotting (a). The densities of the corresponding protein bands were determined with the Molecular Imager and Imaging Densitometer from Bio-Rad Laboratories (Hercules, CA, USA) (b) and the other by cellular DNA fragmentation assay ( Figure 4b ). These two methods use different approaches to detect cell death, the former was a routine and well-known method for the assessment of cell death. The latter is to measure DNA fragments, a hallmark of apoptosis. Cell death in both MKN-45 and MKN-28 cells was not significantly affected by either hemin or cadmium at the concentrations used (both at 10 mM), compared with the cells without treatment (data not shown). As expecting, cell death was significantly increased in both MKN-45 and MKN-28 after treatment with rhTNF-a and cycloheximide ( Figure 4a ). The increase in cell death was markedly reduced at the presence of hemin or cadmium. Furthermore, the number of death cells was re-elevated by the kinase inhibitors, SB203580 and PD098059, indicating that both p38 MAPK and ERK were able to intensify the cellular resistance to the cell death stimuli. The regulation of cell death by hemin, cadmium and the kinase inhibitors appeared to be irrespective of p53 status in the cells, as both MKN-45 and MKN-28 cells had similar response to the treatment. The data obtained by cellular DNA fragmentation assay ( Figure 4b ) remarkably resembled the result from MTT assay, suggesting that cell death observed was apoptotic in nature. and MKN-28 cells were cultured in complete medium for 48 h, and subsequently, in serum-free medium for 24 h, and then were exposed to 10 mM hemin or 10 mM cadmium for 4 h, the kinase inhibitors 40 mM SB203580 and 40 mM PD098059 were given 1 h prior to the addition of hemin and cadmium. The cells were then treated by rhTNF-a (5ng/ml) in conjunction with cycloheximide (10 mg) for 3 h. Cell death was assessed by MTT assay (a) and cellular DNA fragmentation ELISA (b). The result of MTT assay was expressed as optical density reading at 570 nm and the lower the value, the more the death cells. The result of cellular DNA fragmentation ELISA was expressed as reading at 450 nm and the more the value, the more the DNA fragment. The data represent a mean of three independent experiments. *Po0.05, **Po0.01, compared with cells treated with hemin or cadmium alone; þ Po0.05, þ þ Po0.01, compared with cells treated with hemin plus rhTNF-a/cycloheximide or cadmium plus rhTNF-a/cycloheximide The upregulation of HO-1 and p21 expression was associated with an increase in nuclear NF-kB level
To address whether the upregulation of HO-1 and p21 expression was associated with NF-kB, we measured the contents of NF-kB in the nuclei of MKN-45 and NKN-28 cells. The result showed that the content of NF-kB in the nuclei of the cells paralleled the upregulation of HO-1 and p21 expression, as the level of NF-kB in both MKN-45 and NKN-28 was significantly increased when the cells were treated with either hemin or cadmium (Figure 5a) . However, the increase in the nuclear NF-kB level was markedly attenuated by p38 MAPK and ERK inhibitors, SB203580 and PD098059. There was a tendency that the influence of p38 MAPK inhibitor was more effective than that of ERK inhibitors. To confirm the role of the nuclear NF-kB in regulation of HO-1 and p21 expression in the cells treated with HO-1 inducers, a super-repressor of NF-kB activity (Ad5IkB), which is a mutated nondegradable IkBa resistant to phosphorylation and degradation, was used to inhibit the translocation of NF-kB to the nucleus. Ad5IkB significantly inhibited the level of HO-1 expression in both MKN-45 and NKN-28 cells treated with either hemin or cadmium, compared with the cells without Ad5IkB treatment or treated control Ad5LacZ (Figure 5b ). Like HO-1, the level of c-IAP2 expression was significantly inhibited by Ad5IkB in both MKN-45 and NKN-28 cells treated with either hemin or cadmium, compared with the cells without Ad5IkB treatment or treated control Ad5LacZ (Figure 5b ).
Caspase-3 activity in these treated and no-treated gastric cancer cells
Caspase-3 activity of the cells paralleled the cellular apoptotic vulnerability. Caspase-3 activity in both MKN-45 and MKN-28 cells was not significantly affected by either hemin or cadmium at the concentrations used (both at 10 mM), compared with the cells without treatment (Figure 6 ). However, caspase-3 activity was significantly increased in both MKN-45 and MKN-28 cells after treatment with rhTNF-a and cycloheximide. The increase in caspase-3 activity was markedly reduced at the presence of hemin or cadmium. Furthermore, caspase-3 activity was re-elevated by the kinase inhibitors, SB203580 and PD098059, indicating that both p38 MAPK and ERK were able to increase caspase-3 proteolytic activity. The regulation of caspase- Figure 5 The role of nuclear NF-kB in the expression of HO-1, p21 and c-IAP2. MKN-45 and MKN-28 cells were cultured as described in Figure 1 . At the end of the culture, the nuclear protein was extracted. The concentration of nuclear NF-kB was determined using chemiluminescence-based sandwich ELISA kit. The result was expressed as nanograms of NF-kB in milligrams of nuclear protein and data represent a mean of three independent experiments (a). For NF-kB inhibition experiment, the cells were infected with either Ad5IkB or Ad5LacZ, and then were treated with hemin or cadmium for 4 h. 
Discussion
The development of human cancer is believed to result from the disturbance of balance between proliferation and apoptosis. Defects in the apoptotic pathway allow cells with genetic abnormalities to grow without control. Most cytotoxic and hormonal treatments, as well as radiation, ultimately kill cancer cells by inducing irreparable cellular damage that triggers apoptosis. Consequently, the efficacy of cancer treatments depends not only on the cellular damage they cause but also on the ability of cancer cells to respond to the damage by inducing apoptotic machinery. Accordingly, the regulation of apoptosis has been emerging as one of the promising therapeutic approaches to kill or to stop the growth of cancer cells. The present study demonstrated that apoptosis in human gastric cancer cells could be regulated by HO-1 and p21. It also appears that p21 may act as a downstream molecule in the HO-1 pathway, as the time course study showed that the appearance of HO-1 protein predated the expression of p21. This finding is in agreement with a previous study in which the overexpression of HO-1 results in a significant increase in p21 level and the inhibition of HO-1 activity leads to the downregulation of p21 (Inguaggiato et al., 2001) . The signaling pathway from HO-1 to downstream apoptotic or cell cycle molecules is poorly understood in cancer cells, although there are a number of publications showing HO-1 as an antiapoptotic agent in several types of cells Petrache et al., 2000; Inguaggiato et al., 2001; Liu et al., 2002) . Epithelial cells, fibroblasts, neurons and vascular smooth muscle cells overexpressing HO-1 are resistant to apoptosis induced by chemicals, stress and cytokines, on the other hand, these cells are particularly liable to apoptotic stimuli when HO-1 is inhibited or there is a defect in its Figure 6 Caspase-3 activity in MKN-45 and MKN-28 cells. MKN-45 and MKN-28 cells were cultured in complete medium for 48 h, and subsequently, in serum-free medium for 24 h, and then were exposed to 10 mM hemin or 10 mM cadmium for 4 h, the kinase inhibitors 40 mM SB203580 and 40 mM PD098059 were given 1 h prior to the addition of hemin and cadmium. The cells were then treated by rhTNF-a (5 ng/ml) in conjunction with cycloheximide (10 mg) for 3 h. Caspase-3 activity was measured at 405 nm with correction at 570 nm and expressed in Ac-pNA cleavage or released absorbance. One unit is the amount of enzyme that cleaves 1.0 nmol of the colorimetric substrate Ac-DEVD-pNA per hour at 371C under saturated substrate concentration. The data represent a mean of three independent experiments. *Po0.05, **Po0.01, compared with cells treated with hemin or cadmium alone; þ Po0.05, þ þ Po0.01, compared with cells treated with hemin plus rhTNF-a/cycloheximide or cadmium plus rhTNF-a/cycloheximide expression Petrache et al., 2000; Inguaggiato et al., 2001; Liu et al., 2002) . The mechanism of HO-1 against apoptosis is not clear, but it may be associated with the regulation of redox-active iron in fibroblasts, since the protection of cell from apoptosis by HO-1 is correlated with a decrease in intracellular iron amount (Ferris et al., 1999) . Recent studies suggest a role of p38 MAPK in antiapoptotic pathway of HO-1 (Elbirt et al., 1998; Zhang et al., 2003) . In endothelial cells, HO-1 inhibits apoptosis via enhancing phospho-p38 MAPK activation and antiapoptotic effect of HO-1 can be ablated by transfecting the cell with a p38 MAPK dominant-negative mutant or treating the cell with chemical inhibitors of p38 MAPK (Zhang et al., 2003) . The role of p38 MARK in HO-1-mediated antiapoptotic pathway is also confirmed in the present study on human gastric cancer cells. Our study further demonstrated that the expression of p21 was also positively regulated by p38 MAPK. Since the expression of HO-1 predates the change of p21, it is likely that the level of p21 is not directly regulated by p38 MAPK but through its effect on HO-1 expression. In addition to p38 MAPK, the involvement of ERK in antiapoptotic pathway of HO-1 was also evident in our experiment, as the inhibition of ERK significantly attenuated the levels of HO-1 and p21 in the gastric cancer cells. Similar to the role of p38 MAPK, the effect of ERK on p21 may be through its association with HO-1. This assumption is supported by the fact that the activation of HO-1 promoter requires both p38 MAPK and ERK activities (Elbirt et al., 1998) . Like human gastric cancer cells, the expression of HO-1 in human cervix carcinoma cells is also known to be regulated by both p38 MAPK and ERK . In our experiment, it appeared that the levels of HO-1 and p21 were inhibited more profoundly by SB203580, a p38 MAPK inhibitor, than by PD098059, an ERK inhibitor. However, neither of them could completely block the expression of HO-1 and p21, suggesting the complexity of HO-1 and p21 expression in gastric cancer cells in which molecules other than p38 MAPK and ERK are required.
Both p38 MAPK and ERK are closely associated with NF-kB, an antiapoptotic transcription factor (Chen et al., 2002) . ERK enhances the transcription activity of NF-kB while p38 MAPK is necessary for NFkB-dependent gene expression (Carter et al., 1999; Tuyt et al., 1999) . Inhibition of apoptosis by NF-kB has been reported to be in a p38 MAPK-dependent manner (Zechner et al., 1998) . In the present study, we demonstrated that the upregulation of HO-1 and p21 was associated with an increase in the nuclear NF-kB activity. In the inactivated condition, NF-kB is located in the cytosol as a three-subunit complex consisting of two prototypical subunits of p50 and p65 and an inhibitory subunit called IkB (Gilmore, 1999) . When suitably stimulated, the inhibitory subunit IkB will dissociate from the other two prototypical subunits so that it enables the p50-p65 dimmer to translocate to the nucleus, where it binds to its regulatory elements and activate relevant genes. According to this concept, our finding of the increased nuclear NF-kB activity is an indicator that NF-kB has been functionally activated. Our result further showed that the expression of HO-1 and p21 induced by HO-1 stimuli was reduced to the control level that was without HO-1 stimuli when the cells were treated with a dominant-negative NF-kB inhibitor. This experiment strongly indicates that NFkB plays a critical role in the HO-1 and p21 expression in human gastric cancer cells. It is also suggested by our results that the NF-kB is a signaling molecule connecting p38 MAPK and ERK kinases and HO-1/p21. However, the induction of HO-1 may not be just subjected to the regulation of NF-kB, as the inhibition of the nuclear NF-kB affected the expression of p21 more intense than the expression of HO-1. Nevertheless, considering that NF-kB is constitutively activated in human gastric carcinoma tissue (Sasaki et al., 2001) , our data suggest that the inhibition of NF-kB may provide a potential strategy in the control of gastric cancer cell growth via promoting the apoptosis. The feasibility of this approach is strengthened by another study that the induction of growth inhibition and apoptosis by antitumor components isolated from green tea is associated with the suppression of NF-kB in human gastric cancer cells (Okabe et al., 1999) .
In the present study, we have also shown that the mechanism that the resistance to apoptosis by upregulation of HO-1 and p21 is related to an increase in c-IAP2 level and reduced caspase-3 activity. The c-IAP2 appears to be a downstream molecule of HO-1, as the expression of HO-1 predates the increase of c-IAP2. However, it seems that the changes of c-IAP2 and p21 occur at roughly the same point as it is revealed by the time course study. Although how HO-1 interacts c-IAP2 is not known, IAP molecules participates the antiapoptotic pathway of p38 MAPK and ERK (Erhardt et al., 1999) , both of which have been demonstrated to involve the expression of HO-1 in the present study. p21 can compete with IAP molecules to bind to the cell cycle regulator Cdk4. Once p21 is released from p21/Cdk4 by IAP molecules, it would interact with mitochondrial procaspase-3 to suppress apoptosis (Suzuki et al., 2000; Bortner and Cidlowski, 2002) . This seems to be also true in our present experiment, as changes of c-IAP2 and p21 occur at roughly the same point of time and the activity of caspase-3 is significantly inhibited by elevated p21 and c-IAP2. Therefore, our study suggests that the resistance to apoptosis by HO-1 is through a pathway with elevated c-IAP2 and decreased caspase-3 activity in human gastric cancer cells.
Another important finding in the present study is the association of increased G 0 /G 1 arrest with the induction of HO-1 and p21. Gastric cancer cells arrested in the G 0 / G 1 phases with high levels of HO-1 and p21 displays a significant resistance to apoptosis. Defects in cell cycle checkpoints can result in gene mutation, chromosome damage and aneuploidy, all of which are known to contribute to tumorigenesis. The significance of the G 0 / G 1 arrest in gastric cancer cells with elevated levels of HO-1 and p21 is uncertain at present. Normally, after exposure of cells to genotoxic agents such as free radicals, p21 will be induced by p53-dependent transac-tivation (Waldman et al., 1995) . However, this is not true in the gastric cancer cells we studied. The consequence of the elevated HO-1 and p21 including the increased G 0 /G 1 arrest in our experiments is irrespective of the status of p53. The two gastric cancer cell lines tested, MKN-45 and MKN-28 contain wildtype p53 and the mutant p53, respectively. However, the induction of HO-1 and p21 executes similar effects on various parameters measured in both the cells. Therefore, we conclude that the resistance to apoptosis in gastric cancer cells with elevated HO-1 and p21 is independent of p53 status in a p38 MAPK-and ERKmediated pathway and that this pathway is sensitive to the inhibition of NF-kB.
Materials and methods
Cell culture
Two gastric cancer cell lines, MKN-45 bearing wild-type p53, and MKN-28 containing missense mutation in p53 (codon 251, isoleucine to leucine) (Yokozaki, 2000) , were cultured in RPMI 1640 containing 10% fetal bovine serum (FBS), 100 U/ ml penicillin, 100 mg/ml streptomycin at 371C in a humidified atmosphere of 5% CO 2 /95% air. For the induction of HO-1 and p21, MKN-45 and MKN-28 cells were exposed to hemin (Sigma, St Louis, MO, USA) or cadmium (Sigma, St Louis, MO, USA) for 4 h after they were cultured in complete medium for 48 h, and subsequently, in serum-free medium for 24 h.
Determination of HO-1, p21 and c-IAP2 levels
Western blotting was employed to determine the expression of HO-1 and p21. Briefly, total protein of cultures were extracted from these cultures and samples containing 100 mg of protein were separated on 12% Tris-HCl gel, and were transferred to nitrocellulose membranes (Amersham Biosciences, Piscataway, NJ, USA). To detect the expression of HO-1 protein, a rabbit-anti-human polyclonal HO-1 antibody (StressGen Biotechnologics, Victoria, BC, Canada) was employed, followed by a horseradish peroxidase-conjugated goat-anti-rabbit IgG antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Expression of p21 and c-IAP2 proteins was analysed using rabbit-anti-human polyclonal p21 and c-IAP2 antibodies, respectively (both from Santa Cruz Biotechnology, Santa Cruz, CA, USA) as the primary antibody and polyclonal goatanti-rabbit IgG antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) as the secondary antibody. Anti-human actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used to detect human actin, which was used as a control for equal loading. Detection of the target protein signal was achieved by using a chemiluminescence method (Amersham Biosciences, Piscataway, NJ, USA).
Assessment of cell death and apoptosis
An MTT assay was used to quantify cell death/viability. Cell death was also determined by DNA fragmentation measurement. Briefly, MKN-45 and MKN-28 cells were cultured in complete medium for 48 h, and subsequently, in serum-free medium for 24 h. Cells were then exposed to hemin or cadmium for 4 h. The kinase inhibitors, SB203580 and PD098059 (both from Promega, Madison, WI, USA), were given 1 h prior to the addition of hemin or cadmium.
Thereafter, the cells were treated with 5 ng/ml of rhTNF-a (Promega, Madison, WI, USA) in conjunction with 10 mg of cycloheximide (Sigma, St Louis, MO, USA) for 3 h. Apoptosis was assessed by cellular DNA fragmentation ELIAS kit (Roche Molecular Biochemicals, Mannheim, Germany).
Fluorescence-activated cell sorter analysis
Cell cycle analysis was performed by FACS. Approximately 10 6-10 7 cells were harvested by trypsinization and gently pelleted by centrifugation at 200 g for 5 min. After the centrifugation, cells were washed in cold phosphate-buffered saline (PBS) and resuspended in 0.5 ml of PBS. The suspended cells were transferred dropwise to 4.5 ml of 70% ethanol and fixed for more than 2 h. The ethanol-suspended cells were collected, washed and then suspended in 1 ml of 20 mg/ml propidium iodide (PI, Molecular Probe, Eugene, OR, USA)/ 0.1% (v/v) Triton X-100 staining solution with 200 mg/ml RNase A (Sigma, St Louis, MO, USA) in the dark for 30 min at room temperature. Flow cytometry was performed on a Becton Dickinson FACScan machine, using an excitation wavelength of 488 nm and emission wavelength of 585 nm. DNA content frequency histogram deconvolution software was employed to analyse data.
Nuclear protein extraction and NF-kB activity assay
Nuclear protein was isolated according to the procedure described (Davis et al., 2001) . Briefly, cells were harvested, washed in PBS and collected by centrifugation. The cell pellet was resuspended in 0.5 ml of 10 mM Tris-HCl (pH 7.5)/5 mM MgCl 2 /0.05% (v/v) Triton X-100 and lysed with 20 strokes in a homogenizer. The homogenate was centrifuged at 10 000 g for 15 min at 41C. The nuclear pellet was obtained. The nuclei pellet volume was estimated and the pellet was resuspended in an equal volume of 10 mM Tris-HCl (pH 7.4)/5 mM MgCl 2 , followed by the addition of one nuclear pellet volume of 1 M NaCl/10 mM Tris-HCl (pH 7.4)/4 mM MgCl 2 . The lysing nucleus was left on ice for 30 min and then centrifuged at 10 000 g for 15 min at 41C. The supernatant (nuclear extract) was removed and 80% glycerol was added so that the final glycerol concentration was 20% (v/v). The concentration of the nuclear protein was determined. NF-kB activity was measured by an enzyme immunoassay kit from Oxford Biomedical Research (Oxford, MI, USA), which employed an oligonucleotide containing the DNA-binding NF-kB consensus sequence. If there is any NF-kB presented in the sample, it will specifically bind to the oligonucleotide coated on the plate and the DNA-bound NF-kB can be selectively recognized by the antibody to NF-kB subunit, p50 or p105.
Inhibition of NF-kB
A recombinant replication-deficient adenovirus, Ad5IkB, contains an IkB construct in which serines 32 and 36 are mutated to alanines, driven by the cytomegalovirus promoterenhancer. This mutant IkB cannot be phosphorylated, and therefore irreversibly binds to NF-kB, preventing its activation (Jobin et al., 1998; Xu et al., 1998) . Ad5IkB (a generous gift from Dr D Brenner) was used as previously described (Xu et al., 1998) . The adenovirus, Ad5LacZ, which contains the Escherichia coli b-galactosidase gene, was used as a control. Both viruses were grown in 293 cells and purified as the previous description (Xu et al., 1998) . For adenovirus infection, subconfluent cells (B80%) were infected with virus in serum-free medium at multiplicity of infection (MOI) of 10-500 for 12 h. The virus was then washed off and fresh media containing serum was added to the cells. The cells were cultured for another 12 h before experiments.
Measurement of caspase-3 activity
Caspase-3 activity was measured with Colorimetric Assay Kit (Assay Designs, Ann Arbor, MI, USA). Briefly, MKN-45 and MKN-28 cells were cultured in complete medium for 48 h, and subsequently, in serum-free medium for 24 h. About 3 Â 10 6 cells were then exposed to hemin or cadmium for 4 h. The kinase inhibitors, SB203580 and PD098059 were given 1 h prior to the addition of hemin or cadmium. Thereafter, the cells were treated with 5 ng/ml of rhTNF-a in conjunction with 10 mg of cycloheximide for 3 h. Cells were collected and lysed with chilled lysis buffer (50 mM HEPES (pH 7.5), 150 mM NaCl, 20 mM EDTA, 0.2% Triton X-100, 1 mM PMSF, 10 mg/ ml aprotinin and 5 mM DTT) for 10 min on ice. The lysates were centrifuged for 10 min at 10 000 g, 41C. The supernatant containing 100 mg of protein was incubated with 0.2 mM of Ac-DEVD-pNA, a specific substrate for caspase-3. Caspase-3 activity was measured at 405 nm with correction at 570 nm and expressed in Ac-pNA cleavage or released absorbance.
Statistical analysis
All values were expressed as mean7standard deviation. Statistical comparisons were analysed by the Student's t test using statistical computer software, SPSS for Windows (Release 11.0.1, Chicago, IL, USA). A P-value of less than 0.05 was taken as statistically significant.
Abbreviations CDK, cyclin-dependent kinase; c-IAP2, cellular inhibitor of caspase inbitory protein-2; ERK, extracellular-regulated kinase; FACS, fluorescence-activated cell sorter analysis; HO, heme oxygenase; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay; p21, p21 WAF1/Cip1 ; p38 MAPK, p38 mitogen-activated protein kinase; PBS, phosphate-buffered saline; rhTNF-a, recombinant human TNF-a.
